34 related articles for article (PubMed ID: 8622018)
1. Phase I trial of interleukin-2 and high-dose arginine butyrate in metastatic colorectal cancer.
Douillard JY; Bennouna J; Vavasseur F; Deporte-Fety R; Thomare P; Giacalone F; Meflah K
Cancer Immunol Immunother; 2000 Apr; 49(1):56-61. PubMed ID: 10782866
[TBL] [Abstract][Full Text] [Related]
2. Viruses in colorectal cancer.
Marongiu L; Allgayer H
Mol Oncol; 2022 Apr; 16(7):1423-1450. PubMed ID: 34514694
[TBL] [Abstract][Full Text] [Related]
3. Effects of the combination of As
Zhao C; Wang M; Liu Y; Liang Y; Han L; Chen C
Onco Targets Ther; 2018; 11():3293-3301. PubMed ID: 29910624
[TBL] [Abstract][Full Text] [Related]
4. Could adult hippocampal neurogenesis be relevant for human behavior?
Snyder JS; Cameron HA
Behav Brain Res; 2012 Feb; 227(2):384-90. PubMed ID: 21736900
[TBL] [Abstract][Full Text] [Related]
5. Long-term exposure to zidovudine delays cell cycle progression, induces apoptosis, and decreases telomerase activity in human hepatocytes.
Fang JL; Beland FA
Toxicol Sci; 2009 Sep; 111(1):120-30. PubMed ID: 19541796
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetic optimisation of the treatment of cancer with high dose zidovudine.
Danesi R; Falcone A; Conte PF; Del Tacca M
Clin Pharmacokinet; 1998 Feb; 34(2):173-80. PubMed ID: 9515187
[TBL] [Abstract][Full Text] [Related]
7. Adjuvant chemotherapy in colorectal cancer with high-dose leucovorin and fluorouracil: impact on disease-free survival and overall survival.
Zaniboni A
J Clin Oncol; 1997 Jun; 15(6):2432-41. PubMed ID: 9196159
[TBL] [Abstract][Full Text] [Related]
8. Overview of clinical trials using 5-fluorouracil and leucovorin for the treatment of colorectal cancer.
Arbuck SG
Cancer; 1989 Mar; 63(6 Suppl):1036-44. PubMed ID: 2645042
[TBL] [Abstract][Full Text] [Related]
9. Maximum tolerable doses of intravenous zidovudine in combination with 5-fluorouracil and leucovorin in metastatic colorectal cancer patients. Clinical evidence of significant antitumor activity and enhancement of zidovudine-induced DNA single strand breaks in peripheral nuclear blood cells.
Falcone A; Lencioni M; Brunetti I; Pfanner E; Allegrini G; Antonuzzo A; Andreuccetti M; Malvaldi G; Danesi R; Del Tacca M; Conte PF
Ann Oncol; 1997 Jun; 8(6):539-45. PubMed ID: 9261522
[TBL] [Abstract][Full Text] [Related]
10. Phase II study of 5-fluoruracil leucovorin and azidothymidine in patients with metastatic colorectal cancer.
Clark J; Sikov W; Cummings F; Browne M; Akerley W; Wanebo H; Weitberg A; Kennedy T; Cole B; Bigley J; Beitz J; Darnowski J
J Cancer Res Clin Oncol; 1996; 122(9):554-8. PubMed ID: 8781570
[TBL] [Abstract][Full Text] [Related]
11. Sequence effect of irinotecan and fluorouracil treatment on pharmacokinetics and toxicity in chemotherapy-naive metastatic colorectal cancer patients.
Falcone A; Di Paolo A; Masi G; Allegrini G; Danesi R; Lencioni M; Pfanner E; Comis S; Del Tacca M; Conte P
J Clin Oncol; 2001 Aug; 19(15):3456-62. PubMed ID: 11481350
[TBL] [Abstract][Full Text] [Related]
12. Phase I clinical and pharmacokinetic study of leucovorin and infusional hepatic arterial fluorouracil.
Kerr DJ; Ledermann JA; McArdle CS; Buckels J; Neoptolemos J; Seymour M; Doughty J; Budden J; Taylor I
J Clin Oncol; 1995 Dec; 13(12):2968-72. PubMed ID: 8523062
[TBL] [Abstract][Full Text] [Related]
13. Phase I, pharmacokinetic, and bone marrow drug-level studies of tri-monthly 48-h infusion of high-dose 5-fluorouracil and leucovorin in patients with metastatic colorectal cancers.
Ho YF; Lu WC; Chen RR; Cheng AL; Yeh KH
Anticancer Drugs; 2011 Mar; 22(3):290-8. PubMed ID: 21150775
[TBL] [Abstract][Full Text] [Related]
14. Intravenous azidothymidine with fluorouracil and leucovorin: a phase I-II study in previously untreated metastatic colorectal cancer patients.
Falcone A; Danesi R; Dargenio F; Pfanner E; Brunetti I; Del Tacca M; Nethersell AB; Conte PF
J Clin Oncol; 1996 Mar; 14(3):729-36. PubMed ID: 8622018
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
